Harness IP
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
  • Careers
  • Contact Us
    • 한국어
    • 日本語
    • 中國語
  • Client Login
  • 한국어
  • 日本語
  • 中國語

Blog

Subscribe to our Blogs

  • Subscribe to our Blogs

Harness IP takes pride in our collective knowledge of intellectual property law and how it affects businesses and organizations across a range of industries. We also enjoy keeping up with the latest decisions from the prominent venues that affect IP law, including the Federal Circuit, the U.S. Supreme Court, and the PTAB. Our goal is to distill this knowledge into practical guidance that in-house counsel and others can use. We invite you to join our audience and enrich the discussion whenever possible. 

  • Biologics & Biosimilars

      ALL CATEGORIES

      • Biologics & Biosimilars
        • FDA Guidance & Updates
      • BioPharma
      • Blockchain, Crypto, & Web 3.0
      • Chemistry & Nanotechnology
      • EDMO Patent Updates
      • Fitness IP
      • IP Management
      • IPR-PGR
      • Litigation
      • Patent Prosecution
      • quIPs
      • Trademarks
      • Uncategorized
  • Authors
    • Jewell N. BriggsJewell N. Briggs 8
    • John A. Castellano, IIIJohn A. Castellano, III 1
    • Christopher M. CaubleChristopher M. Cauble 5
    • Matthew L. CutlerMatthew L. Cutler 201
    • Keith P. DriscollKeith P. Driscoll 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 7
    • Monte L. FalcoffMonte L. Falcoff 3
    • Glenn E. ForbisGlenn E. Forbis 11
    • Charlie Franklin, Ph.D.Charlie Franklin, Ph.D. 1
    • Alexandra M. FuchsAlexandra M. Fuchs 2
    • Michael GambleMichael Gamble 1
    • Jordyn GraweJordyn Grawe 9
    • Jason A. HeistJason A. Heist 1
    • Paul R. HofferPaul R. Hoffer 2
    • Michael P. KellaMichael P. Kella 3
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 11
    • Kisuk LeeKisuk Lee 2
    • J. Bradley (Brad) LuchsingerJ. Bradley (Brad) Luchsinger 1
    • Chris K. MillerChris K. Miller 1
    • Leanne M. RakersLeanne M. Rakers 35
    • Douglas A. RobinsonDouglas A. Robinson 18
    • Joel R. SamuelsJoel R. Samuels 16
    • Mark A. SpinelliMark A. Spinelli 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • David P. UtykanskiDavid P. Utykanski 1
    • Michael VarcoMichael Varco 3
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 4
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 719
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 12
    • Scott E. YackeyScott E. Yackey 1
  • Protecting-Your-Cannabis-Brands_Harness-IP

    January 2, 2025

    Navigating Complex Federal Regulations When Protecting Your Cannabis Brands

    More

  • FDA NIH | Intellectual Property Law Firm | Harness IP

    December 16, 2024

    20 March 2024 USPTO Alert: USPTO ensures robust and reliable patents through examiner training on searching for prior art in FDA and NIH databases

    More

  • The 7 Things You Don’t Say (In Writing) When Your Company is Accused of Patent Infringement

    November 19, 2024

    The 7 Things You Don’t Say (In Writing) When Your Company is Accused of Patent Infringement

    More

  • Don’t Disclaim-Away the Broader Claims in Your Continuation

    November 19, 2024

    Don’t Disclaim-Away the Broader Claims in Your Continuation Patent Application

    More

  • Middle Market IP on NCMM Podcast

    November 19, 2024

    Joe Walsh and Bryan Wheelock Talk Middle Market IP on NCMM Podcast

    More

  • gaming assets Trademark Lawyer

    November 11, 2024

    “Trademark tactics for safeguarding gaming assets,” The Trademark Lawyer

    More

FDA NIH | Intellectual Property Law Firm | Harness IP

December 16, 2024

20 March 2024 USPTO Alert: USPTO ensures robust and reliable patents through examiner training on searching for prior art in FDA and NIH databases

By: Leanne M. Rakers, Principal; Jordyn Grawe, Patent Agent

Extrinsic-Evidence_Harness-IP_Intellectual-Property-Law-Firm

November 6, 2023

Extrinsic Evidence Needed to Construe Numerical Limitation in the Claims

By: Bryan K. Wheelock, Principal

WIPO Standard ST.26 Tips_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP

October 5, 2022

WIPO Standard ST.26 Tips as of 16 August 2022

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

WIPO resources_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP

September 28, 2022

WIPO ST.26 Resources

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

WIPO sequence features_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_

September 21, 2022

Features of WIPO Sequence

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

WIPO ST.25 vs ST.26_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_

September 13, 2022

ST.25 vs. ST.26 Sequence Listings

By: Leanne M. Rakers, Principal; Jordyn Grawe, Patent Agent

WIPO ST.26_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_

September 7, 2022

WIPO ST.26 Overview

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

Harness IP_Intellectual Property_The Big Bang Blog Series_WIPO .26 Standards

August 30, 2022

The Big Bang Blog Series – The New WIPO Standard

By:

FDA Guidance Biosimilars Patent Prosecution | Intellectual Property Law Firm | Harness IP

September 20, 2019

FDA Publishes New Guidance Limiting Petitions that Could Delay Biosimilar Applications

By: Leanne M. Rakers, Principal

photo of biosimilar medications

February 7, 2019

Abandoning Infringing Conduct Caused Loss of Standing to Appeal IPR

By: Bryan K. Wheelock, Principal

Harness IP Intellectual Property Lawyers

August 20, 2018

Pfizer’s Biosimilar Antitrust Lawsuit Survives Johnson & Johnson’s Motion to Dismiss

By: Elisabeth A. Koral, Principal

photo of laboratory and scientist creating biosimilar patents

August 9, 2018

FDA Implements Biosimilar Action Plan to Boost Biosimilar Competition

By: Leanne M. Rakers, Principal

image of light bulb to suggest hypothetical biosimilar case study

August 9, 2018

At Risk Launch: A Hypothetical Case Study

By: Douglas A. Robinson, Principal

photo of chess pieces representing biosimilar competitive dynamics

August 8, 2018

Competitor Influence on the Conduct of the Patent Dance and Litigation

By: Elisabeth A. Koral, Principal

photo of biosimilar medications

August 7, 2018

Seeking Biosimilar Market Entry When a Competitor is Pursuing Interchangeability: Factors to Consider

By: Elisabeth A. Koral, Principal

Stay Current on all things IP by subscribing to our blog

Join

  • LinkedIn
  • Facebook
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2025 Harness, Dickey & Pierce, P.L.C. All rights reserved. H D & P